BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/25/2021 2:33:12 AM | Browse: 434 | Download: 973
 |
Received |
|
2021-03-02 07:52 |
|
Peer-Review Started |
|
2021-03-02 07:58 |
|
First Decision by Editorial Office Director |
|
2021-06-03 23:33 |
|
Return for Revision |
|
2021-06-03 23:33 |
|
Revised |
|
2021-07-03 14:24 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-07-12 03:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-07-12 09:00 |
|
Articles in Press |
|
2021-07-12 09:00 |
|
Edit the Manuscript by Language Editor |
|
2021-07-27 19:35 |
|
Typeset the Manuscript |
|
2021-08-10 06:42 |
|
Publish the Manuscript Online |
|
2021-08-25 02:11 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Microbiology |
| Manuscript Type |
Minireviews |
| Article Title |
Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yong-Bo Kang and Yue Cai |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Science Research Start-up Fund for Doctor of Shanxi Medical University |
XD180 |
| Science Research Start-up Fund for Doctor of Shanxi Province |
SD1807 |
| Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi |
2019L0425 |
| Shanxi Province Science Foundation for Youths |
201901D211314 |
|
| Corresponding Author |
Yong-Bo Kang, PhD, Associate Professor, Department of Microbiology and Immunology, School of Basic Medical Sciences, Shanxi Medical University, Zhongdu Campus, Yuci District, Jinzhong 030600, Shanxi Province, China. 657151276@qq.com |
| Key Words |
Gut microbiome; Immunotherapy; Programmed cell death protein 1/programmed cell death protein ligand 1; Cytotoxic T-lymphocyte-associated protein 4; Immune checkpoint inhibitors resistance; Faecal microbiota transplantion |
| Core Tip |
Gut microbiota composition is closely associated with the efficacy of immune checkpoint inhibitors (ICIs). Specific species among the intestinal commensal bacteria may play a key role in the efficacy of ICIs against cancer. Faecal microbiota transplantation may enhance efficacy of ICIs. |
| Publish Date |
2021-08-25 02:11 |
| Citation |
Kang YB, Cai Y. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer. World J Gastroenterol 2021; 27(32): 5362-5375
|
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i32/5362.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i32.5362 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
